{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:18:29Z","timestamp":1784852309411,"version":"3.55.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["WU21Q0"],"award-info":[{"award-number":["WU21Q0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["WU23GE0"],"award-info":[{"award-number":["WU23GE0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["WU20D0"],"award-info":[{"award-number":["WU20D0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["OLIVER22A0-KB"],"award-info":[{"award-number":["OLIVER22A0-KB"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["LINNEM22QI0"],"award-info":[{"award-number":["LINNEM22QI0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21DK128731"],"award-info":[{"award-number":["R21DK128731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00HL151965"],"award-info":[{"award-number":["R00HL151965"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical &amp; Translational Endocrinology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jcte.2024.100344","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T03:09:19Z","timestamp":1713668959000},"page":"100344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Racial inequities and rare CFTR variants: Impact on cystic fibrosis diagnosis and treatment"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2177-4414","authenticated-orcid":false,"given":"Malinda","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanicia","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7781-7006","authenticated-orcid":false,"given":"Kathryn E.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2024.100344_b0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.med.0000436191.87727.ec","article-title":"Cystic fibrosis-related bone disease: insights into a growing problem","volume":"20","author":"Stalvey","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jcte.2024.100344_b0010","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.dld.2014.06.011","article-title":"Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy","volume":"46","author":"Li","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jcte.2024.100344_b0015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-2362.2001.00876.x","article-title":"Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency","volume":"31","author":"Walkowiak","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jcte.2024.100344_b0020","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2024.100344_b0025","unstructured":"Padoa C, Goldman A, Jenkins T, Ramsay M. Cystic fibrosis carrier frequencies in populations of African origin. J Med Genet 1999;36:41-4. No DOI available."},{"key":"10.1016\/j.jcte.2024.100344_b0030","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1002\/ppul.25658","article-title":"Outcomes of infants born during the first 9 years of CF newborn screening in the United States: a retrospective Cystic Fibrosis Foundation Patient Registry cohort study","volume":"56","author":"Martiniano","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcte.2024.100344_b0035","author":"Cystic Fibrosis Foundation Patient Registry"},{"key":"10.1016\/j.jcte.2024.100344_b0040","first-page":"1721","article-title":"Minorities are underrepresented in clinical trials of pharmaceutical agents for cystic fibrosis","volume":"13","author":"McGarry","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcte.2024.100344_b0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1378\/chest.14-2189","article-title":"Assessing differences in mortality rates and risk factors between hispanic and non-hispanic patients with cystic fibrosis in California","volume":"149","author":"Buu","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jcte.2024.100344_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1513\/AnnalsATS.201606-481FR","article-title":"Cystic fibrosis in the african diaspora","volume":"14","author":"Stewart","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcte.2024.100344_b0055","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.201711-2357OC","article-title":"Disparities in mortality of hispanic patients with cystic fibrosis in the United States. A national and regional cohort study","volume":"198","author":"Rho","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcte.2024.100344_b0060","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/ppul.23884","article-title":"Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: a longitudinal analysis","volume":"52","author":"McGarry","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl 3","key":"10.1016\/j.jcte.2024.100344_b0065","first-page":"S74","article-title":"The demographics of adverse outcomes in cystic fibrosis","volume":"54","author":"McGarry","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcte.2024.100344_b0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jmoldx.2015.07.005","article-title":"The spectrum of CFTR variants in nonwhite cystic fibrosis patients: implications for molecular diagnostic testing","volume":"18","author":"Schrijver","year":"2016","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jcte.2024.100344_b0075","doi-asserted-by":"crossref","unstructured":"Zampoli On Behalf Of The Msac M. Cystic fibrosis: What's new in South Africa in 2019. S Afr Med J 2018;109:16-9. 10.7196\/SAMJ.2018.v109i1.13415.","DOI":"10.7196\/SAMJ.2018.v109i1.13415"},{"key":"10.1016\/j.jcte.2024.100344_b0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jgc4.1271","article-title":"The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine","volume":"29","author":"Januska","year":"2020","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jcte.2024.100344_b0085","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.201901-0145OC","article-title":"Correlating cystic fibrosis transmembrane conductance regulator function with clinical features to inform precision treatment of cystic fibrosis","volume":"199","author":"McCague","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcte.2024.100344_b0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coph.2017.09.018","article-title":"Transformative therapies for rare CFTR missense alleles","volume":"34","author":"Oliver","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jcte.2024.100344_b0095","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcf.2019.02.009","article-title":"Decreased mRNA and protein stability of W1282X limits response to modulator therapy","volume":"18","author":"Aksit","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2024.100344_b0100","first-page":"7454","article-title":"Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells","volume":"48","author":"Michaels","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcte.2024.100344_b0105","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/ppul.25285","article-title":"Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype","volume":"56","author":"McGarry","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcte.2024.100344_b0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00125817-200103000-00010","article-title":"Laboratory standards and guidelines for population-based cystic fibrosis carrier screening","volume":"3","author":"Grody","year":"2001","journal-title":"Genet Med"},{"key":"10.1016\/j.jcte.2024.100344_b0115","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcte.2024.100344_b0120","unstructured":"The Clinical and Functional TRanslation of CFTR (CFTR2). https:\/\/cftr2.org\/ [accessed 20 November 2023]."},{"key":"10.1016\/j.jcte.2024.100344_b0125","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.GIM.0000139503.22088.66","article-title":"CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations","volume":"6","author":"Sugarman","year":"2004","journal-title":"Genet Med"},{"key":"10.1016\/j.jcte.2024.100344_b0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ahg.12396","article-title":"Carrier frequency of CFTR variants in the non-Caucasian populations by genome aggregation database (gnomAD)-based analysis","volume":"84","author":"Nappo","year":"2020","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.jcte.2024.100344_b0135","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/gim.2015.157","article-title":"Cystic fibrosis on the African continent","volume":"18","author":"Stewart","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.jcte.2024.100344_b0140","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jcf.2019.09.007","article-title":"Cystic fibrosis in black African children in South Africa: a case control study","volume":"19","author":"Owusu","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2024.100344_b0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/adc.66.3.307","article-title":"Appendicitis in cystic fibrosis","volume":"66","author":"Shields","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcte.2024.100344_b0150","first-page":"7186258","article-title":"Scoliosis surgery in cystic fibrosis: surgical considerations and the multidisciplinary approach of a rare case","volume":"2016","author":"Mataliotakis","year":"2016","journal-title":"Case Rep Orthop"},{"key":"10.1016\/j.jcte.2024.100344_b0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcf.2022.12.009","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on annual rate of lung function decline in people with cystic fibrosis","volume":"22","author":"Lee","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2024.100344_b0160","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/thx.51.4.374","article-title":"Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic","volume":"51","author":"Muhdi","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.jcte.2024.100344_b0165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/ajrccm.164.1.2011153","article-title":"Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis","volume":"164","author":"LiPuma","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcte.2024.100344_b0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ppul.20619","article-title":"Predictors of mortality in adults with cystic fibrosis","volume":"42","author":"Courtney","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcte.2024.100344_b0175","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis-related diabetes","volume":"146","author":"Marshall","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcte.2024.100344_b0180","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc08-0466","article-title":"Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults","volume":"31","author":"Adler","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2024.100344_b0185","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jcf.2019.04.015","article-title":"Incidence and risk factors of paediatric cystic fibrosis-related diabetes","volume":"18","author":"Perrem","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2024.100344_b0190","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00125-009-1436-2","article-title":"A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis","volume":"52","author":"Blackman","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2024.100344_b0195","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/clinem\/dgz102","article-title":"Genetic modifiers of cystic fibrosis-related diabetes have extensive overlap with type 2 diabetes and related traits","volume":"105","author":"Aksit","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2024.100344_b0200","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1001\/jama.2014.3201","article-title":"Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009","volume":"311","author":"Dabelea","year":"2014","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jcte.2024.100344_b0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/thx.2005.051029","article-title":"Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease","volume":"61","author":"Baker","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.jcte.2024.100344_b0210","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00154-2016","article-title":"The prevalence of diagnosed \u03b11-antitrypsin deficiency and its comorbidities: results from a large population-based database","volume":"49","author":"Greulich","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcte.2024.100344_b0215","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1164\/rccm.201909-1813OC","article-title":"Evidence for exacerbation-prone asthma and predictive biomarkers of exacerbation frequency","volume":"202","author":"Peters","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcte.2024.100344_b0220","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61330","article-title":"Obesity and diabetes as comorbidities for COVID-19: underlying mechanisms and the role of viral-bacterial interactions","volume":"9","author":"Kruglikov","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jcte.2024.100344_b0225","article-title":"Cystic fibrosis-related diabetes: prevalence, screening, and diagnosis","volume":"27","author":"Khare","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcte.2024.100344_b0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-8227(99)00058-3","article-title":"Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report","volume":"45","author":"Moran","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcte.2024.100344_b0235","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcte.2024.100344_b0240","article-title":"Cystic fibrosis related diabetes (CFRD) prognosis","volume":"26","author":"Sandouk","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcte.2024.100344_b0245","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0035-1547319","article-title":"Clinical updates in cystic fibrosis-related diabetes","volume":"36","author":"Brennan","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jcte.2024.100344_b0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis","volume":"6","author":"Brennan","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2024.100344_b0255","doi-asserted-by":"crossref","first-page":"e76283","DOI":"10.1371\/journal.pone.0076283","article-title":"Elevated paracellular glucose flux across cystic fibrosis airway epithelial monolayers is an important factor for Pseudomonas aeruginosa growth","volume":"8","author":"Garnett","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcte.2024.100344_b0260","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jcf.2012.09.005","article-title":"Progression of structural lung disease on CT scans in children with cystic fibrosis related diabetes","volume":"12","author":"Widger","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2024.100344_b0265","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/gtmb.2009.0028","article-title":"Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia","volume":"13","author":"Fredj","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.jcte.2024.100344_b0270","doi-asserted-by":"crossref","unstructured":"Petrova NV, Kashirskaya NY, Vasilyeva TA, Kondratyeva EI, Zhekaite EK, Voronkova AY, et al. Analysis of CFTR mutation spectrum in ethnic russian cystic fibrosis patients. Genes (Basel) 2020;11. 10.3390\/genes11050554.","DOI":"10.3390\/genes11050554"},{"key":"10.1016\/j.jcte.2024.100344_b0275","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13023-020-01393-w","article-title":"Characterization of clinical and genetic spectrum of Chinese patients with cystic fibrosis","volume":"15","author":"Liu","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jcte.2024.100344_b0280","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/humu.23276","article-title":"CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants","volume":"38","author":"Claustres","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jcte.2024.100344_b0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2019.02.015","article-title":"Mutational analysis of CFTR in the Ecuadorian population using next-generation sequencing","volume":"696","author":"Ruiz-Cabezas","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.jcte.2024.100344_b0290","article-title":"The role of modulators in cystic fibrosis related diabetes","volume":"27","author":"Merjaneh","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcte.2024.100344_b0295","doi-asserted-by":"crossref","unstructured":"Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation. J Pediatr 2017;181s:S4-S15.e1. 10.1016\/j.jpeds.2016.09.064.","DOI":"10.1016\/j.jpeds.2016.09.064"},{"key":"10.1016\/j.jcte.2024.100344_b0300","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic fibrosis foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcte.2024.100344_b0305","first-page":"1","article-title":"Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs","volume":"53","author":"Grosse","year":"2004","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jcte.2024.100344_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.113595","article-title":"Late diagnosis in the era of universal newborn screening negatively affects short- and long-term growth and health outcomes in infants with cystic fibrosis","volume":"262","author":"Martiniano","year":"2023","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcte.2024.100344_b0315","doi-asserted-by":"crossref","unstructured":"Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, et al. Diagnosis of cystic fibrosis in screened populations. J Pediatr 2017;181s:S33-S44.e2. 10.1016\/j.jpeds.2016.09.065.","DOI":"10.1016\/j.jpeds.2016.09.065"},{"key":"10.1016\/j.jcte.2024.100344_b0320","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1067\/mpd.2002.129845","article-title":"The impact of early cystic fibrosis diagnosis on pulmonary function in children","volume":"141","author":"Wang","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcte.2024.100344_b0325","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1001\/jama.2021.5086","article-title":"Tackling the misconception that cystic fibrosis is a \u201cwhite people's disease\u201d","volume":"325","author":"Rubin","year":"2021","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jcte.2024.100344_b0330","article-title":"Evaluating differences in the disease experiences of minority adults with cystic fibrosis","volume":"9","author":"Hutchins","year":"2022","journal-title":"J Patient Exp"},{"key":"10.1016\/j.jcte.2024.100344_b0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcf.2022.07.010","article-title":"Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening","volume":"22","author":"McColley","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2024.100344_b0340","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/10784535231216461","article-title":"The lived experience of african american persons with cystic fibrosis","volume":"29","author":"Ladores","year":"2023","journal-title":"Creat Nurs"},{"key":"10.1016\/j.jcte.2024.100344_b0345","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ppul.20824","article-title":"Elevated IRT levels in African-American infants: implications for newborn screening in an ethnically diverse population","volume":"43","author":"Giusti","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcte.2024.100344_b0350","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1542\/peds.2006-1415","article-title":"New York State cystic fibrosis consortium: the first 2.5 years of experience with cystic fibrosis newborn screening in an ethnically diverse population","volume":"119","author":"Giusti","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcte.2024.100344_b0355","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-0004.2010.01502.x","article-title":"Understanding the population structure of North American patients with cystic fibrosis","volume":"79","author":"Li","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.jcte.2024.100344_b0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/gim.2016.48","article-title":"Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients","volume":"19","author":"Pique","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.jcte.2024.100344_b0365","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ppul.26209","article-title":"Detection of disease-causing CFTR variants in state newborn screening programs","volume":"58","author":"McGarry","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcte.2024.100344_b0370","unstructured":"TRIKAFTA prescribing information. https:\/\/www.trikaftahcp.com\/ [accessed 20 November 2023]."},{"key":"10.1016\/j.jcte.2024.100344_b0375","unstructured":"SYMDEKO prescribing information. https:\/\/www.symdekohcp.com\/ [accessed 20 November 2023]."},{"key":"10.1016\/j.jcte.2024.100344_b0380","unstructured":"ORKAMBI prescribing information. https:\/\/www.orkambi.com\/ [accessed 20 November 2023]."},{"key":"10.1016\/j.jcte.2024.100344_b0385","unstructured":"KALYDECO prescribing information. https:\/\/www.kalydeco.com\/ [accessed 20 November 2023]."},{"key":"10.1016\/j.jcte.2024.100344_b0390","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-020-0822-5","article-title":"CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Deignan","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.jcte.2024.100344_b0395","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/gim.2014.209","article-title":"Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study","volume":"18","author":"Baker","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.jcte.2024.100344_b0400","first-page":"6","article-title":"Translating molecular technologies into routine newborn screening practice","author":"Furnier","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jcte.2024.100344_b0405","first-page":"7","article-title":"Validation of a custom next-generation sequencing assay for cystic fibrosis newborn screening","author":"Sicko","year":"2021","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jcte.2024.100344_b0410","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/gim.2017.32","article-title":"Genomic sequencing in cystic fibrosis newborn screening: what works best, two-tier predefined CFTR mutation panels or second-tier CFTR panel followed by third-tier sequencing?","volume":"19","author":"Currier","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.jcte.2024.100344_b0415","first-page":"4","article-title":"Newborn screening quality assurance program for CFTR mutation detection and gene sequencing to identify cystic fibrosis","author":"Hendrix","year":"2016","journal-title":"J Inborn Errors Metab Screen"},{"key":"10.1016\/j.jcte.2024.100344_b0420","doi-asserted-by":"crossref","first-page":"e0138511","DOI":"10.1371\/journal.pone.0138511","article-title":"Racism as a determinant of health: a systematic review and meta-analysis","volume":"10","author":"Paradies","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcte.2024.100344_b0425","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","article-title":"Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries","volume":"69","author":"Quittner","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jcte.2024.100344_b0430","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00127-022-02307-w","article-title":"Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: a systematic review and meta-analysis","volume":"58","author":"Lord","year":"2023","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.jcte.2024.100344_b0435","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1378\/chest.06-2474","article-title":"The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis","volume":"132","author":"Riekert","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jcte.2024.100344_b0440","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4187\/respcare.06356","article-title":"Health-related quality of life in adolescents and adults with cystic fibrosis: physical and mental health predictors","volume":"64","author":"Cronly","year":"2019","journal-title":"Respir Care"},{"key":"10.1016\/j.jcte.2024.100344_b0445","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1186\/s40064-016-2862-5","article-title":"Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis","volume":"5","author":"Knudsen","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.jcte.2024.100344_b0450","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcf.2020.07.020","article-title":"Decreased survival in cystic fibrosis patients with a positive screen for depression","volume":"20","author":"Schechter","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2024.100344_b0455","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0033291710000401","article-title":"Race\/ethnic differences in exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United States","volume":"41","author":"Roberts","year":"2011","journal-title":"Psychol Med"},{"key":"10.1016\/j.jcte.2024.100344_b0460","first-page":"152","article-title":"Trends and disparities in firearm deaths among children","author":"Roberts","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcte.2024.100344_b0465","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/TA.0000000000003167","article-title":"Firearm homicide mortality is influenced by structural racism in US metropolitan areas","volume":"91","author":"Houghton","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jcte.2024.100344_b0470","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.chiabu.2018.10.004","article-title":"Victimization and traumatic stress: Pathways to depressive symptoms among low-income African-American girls","volume":"86","author":"Gershon","year":"2018","journal-title":"Child Abuse Negl"},{"key":"10.1016\/j.jcte.2024.100344_b0475","doi-asserted-by":"crossref","first-page":"e2329825","DOI":"10.1001\/jamanetworkopen.2023.29825","article-title":"Structural racism and adolescent mental health disparities in Northern California","volume":"6","author":"Acker","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcte.2024.100344_b0480","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.acap.2021.05.026","article-title":"Structuring poverty: how racism shapes child poverty and child and adolescent health","volume":"21","author":"Heard-Garris","year":"2021","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.jcte.2024.100344_b0485","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1176\/appi.ajp.21101000","article-title":"The intergenerational impact of structural racism and cumulative trauma on depression","volume":"179","author":"Hankerson","year":"2022","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jcte.2024.100344_b0490","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.amepre.2023.06.017","article-title":"Structural racism and well-being among young people in the U.S","volume":"65","author":"Anderson","year":"2023","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jcte.2024.100344_b0495","unstructured":"Cystic Fibrosis Foundation. External Racial Justice Working Group: Final Recommendations. https:\/\/www.cff.org\/news\/2023-10\/foundation-formalizes-final-recommendations-ERJWG [accessed 18 February 2024]."},{"key":"10.1016\/j.jcte.2024.100344_b0500","unstructured":"Institute NHGR. Talking glossary of genetic terms. https:\/\/www.genome.gov\/genetics-glossary [accessed 20 November 2023]."},{"key":"10.1016\/j.jcte.2024.100344_b0505","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcte.2024.100344_b0510","first-page":"10","article-title":"Therapeutic approaches for patients with cystic fibrosis not eligible for current CFTR modulators","author":"Fajac","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jcte.2024.100344_b0515","first-page":"14","article-title":"State of the art on approved cystic fibrosis transmembrane conductance regulator (CFTR) modulators and triple-combination therapy","author":"Meoli","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jcte.2024.100344_b0520","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1073\/pnas.87.21.8447","article-title":"Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene","volume":"87","author":"Kerem","year":"1990","journal-title":"PNAS"},{"key":"10.1016\/j.jcte.2024.100344_b0525","first-page":"118","article-title":"Positive epistasis between disease-causing missense mutations and silent polymorphism with effect on mRNA translation velocity","author":"Rauscher","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.jcte.2024.100344_b0530","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00439-005-0065-1","article-title":"Extensive sequencing of the CFTR gene: lessons learned from the first 157 patient samples","volume":"118","author":"McGinniss","year":"2005","journal-title":"Hum Genet"}],"container-title":["Journal of Clinical &amp; Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:19:14Z","timestamp":1718900354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623724000152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":106,"alternative-id":["S2214623724000152"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100344","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial inequities and rare CFTR variants: Impact on cystic fibrosis diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100344"}}